Resistance to artemisinin-based combination therapy

The Lancet Infectious Diseases

Volumn 12, Issue 11, 2012, Pages 820-822

  Breman, Joel G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTEMISININ DERIVATIVE; HEMOGLOBIN E; MEFLOQUINE; PRIMAQUINE; TAFENOQUINE;

AFRICA; CAMBODIA; DISEASE TRANSMISSION; DRUG IDENTIFICATION; DRUG MARKETING; DRUG QUALITY; FOOD AND DRUG ADMINISTRATION; GAMETOCYTE; GENE LOCUS; GENOME; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; IN VITRO STUDY; INFECTION SENSITIVITY; LETTER; MALARIA CONTROL; MALARIA FALCIPARUM; MYANMAR; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SOUTHEAST ASIA; VECTOR CONTROL;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM;

EID: 84867918286     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70226-8     Document Type: Letter

References (8)

1. Dondorp AM, Nosten F, Yi P, Das D, et al. Artemisinin resistance in Plasmodium falciparum malaria. New Engl J Med 2009, 361:455-467.
2. Amaratunga C, Sreng S, Suon S, et al. Artemisinin-resistant Plasmodium falciparum malaria in Pursat province, western Cambodia: a parasite-clearance-rate study. Lancet Infect Dis 2012, published online Aug 30. http://dx.doi.org/10.1016/S1473-3099(12)70181-0.
3. Cheeseman IH, Miller BA, Nair S, et al. A major genome region underlying artemisinin resistance in malaria. Science 2012, 336:79-82.
4. Global report on antimalarial efficacy and drug resistance: 2000-2010 WHO, (accessed Aug 22, 2012). http://www.who.int/malaria/publications/atoz/9789241500470/en/index.html.
5. Baliraine FN, Rosenthal PJ Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis 2011, 204:1120-1124.
6. Ferreira PE, Culleton R Dynamics of Plasmodium falciparum selection after artemether-lumefantrine treatment in Africa. J Infect Dis 2012, 205:1473-1475.
7. Fairhurst RM, Nayyar GML, Breman JG, et al. Artemisinin-resistant malaria: research challenges, opportunities, and public health priorities. Am J Trop Med Hygiene 2012, 87:231-241.
8. Nayyar GML, Breman JG, Newton PN, Herrington J Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis 2012, 12:488-496.